From egg freezing and IVF, to ovarian disease and menopause

Gameto is a first-of-its-kind biotechnology company on a mission to address significant unmet needs for women and families throughout their reproductive years — and beyond. 

Transforming reproductive health using modern science

Gameto’s groundbreaking cell engineering platform has the potential to solve many of the problems at the heart of the global infertility crisis.

The first application of our technology, Fertilo, aims to improve the current IVF and egg freezing landscape using engineered ovarian support cells.

Fertilo

Our lead program. Improving outcomes for IVF and other fertility methods.

Deovo

Testing and developing drugs for ovarian disease.

Ameno

Making the medical burden of menopause optional.

Scientists, innovators, entrepreneurs, parents.

Our team understands firsthand the importance of improving the experience for patients seeking family-building solutions. Our mission to transform reproductive health guides everything we do.

Because women and families deserve more.

Infertility impacts 1 in 6 people worldwide, including our own friends, family, and colleagues. This fight is personal for us, because it’s personal for everyone.

We believe everyone deserves access to solutions that give them the best chance at achieving their family planning goals and dreams.

Gameto in the News